Saxenda® vs Zepbound® for weight management

Saxenda® vs Zepbound® is a fair thing to weigh if you want help managing your weight. Both are real options.

Maybe your doctor named one and a friend takes the other. You want to know which fits your life. That is a smart question.

Here is the calm version. These are two different medicines with one shared job. The daily or weekly rhythm is a big part of the choice.

In animal studies, these drugs caused thyroid C-cell tumors in rodents. Whether this happens in people is not known.

Do not use either brand if you or a family member has had medullary thyroid cancer (MTC) or MEN 2.

Tell your doctor about any lump or swelling in your neck, trouble swallowing, or a hoarse voice.

Saxenda® vs Zepbound®: how they compare

Saxenda® vs Zepbound® is not one drug with two names. These are two different medicines. They just share one goal, weight management.

Saxenda® is a brand of liraglutide. Zepbound® is a brand of tirzepatide. Those are two separate molecules.

The biggest day-to-day split is timing. Saxenda® is a daily injection. Zepbound® is a once-weekly injection.

Both are meant to be used with a lower-calorie diet and more activity. The shot is a tool, not a stand-in for habits.

So the real questions are how they fit your week and how much change each one showed. Let me walk through both.

Two different medicines, one shared job. The rhythm, daily or weekly, is a big part of the choice.

How the medicine works in each brand

Saxenda® works on one gut hormone pathway called GLP-1. It can help you feel full sooner and slow how fast your stomach empties.

Zepbound® works on two pathways at once, GIP and GLP-1. It can also curb appetite and slow stomach emptying.

In plain terms, both can make it easier to eat less without white-knuckling it. That is the shared idea behind each brand.

The difference in pathways is one reason the brands are dosed and studied on their own. Each was tested in its own trial.

What Saxenda® is approved to do

Saxenda® (brand of liraglutide) is approved for chronic weight management. It is a daily shot you give yourself under the skin.

It is for adults with obesity. It also covers adults who are overweight with at least one weight-related health problem.

The label also covers some kids 12 and up who weigh more than 60 kg and have obesity. Your clinician confirms if that fits.

The weight data comes from a trial called SCALE. It ran 56 weeks and enrolled 3,731 adults.

In SCALE, Saxenda® showed about -7.4% mean body-weight change. Placebo showed about -3.0%.

That study split roughly 2,487 people on Saxenda® and 1,244 on placebo. The gap between them was about 4.5 points.

What Zepbound® is approved to do

Zepbound® (brand of tirzepatide) is approved for chronic weight management. It is a once-weekly shot under the skin.

Like Saxenda®, it is for adults with obesity, or adults who are overweight with a weight-related health problem. Zepbound® also has a separate approval for moderate-to-severe obstructive sleep apnea in adults with obesity.

The weight data comes from a trial called SURMOUNT-1. It ran 72 weeks and enrolled 2,539 adults.

At the top 15 mg dose, Zepbound® showed about -20.9% mean body-weight change. Placebo showed about -3.1%.

The 10 mg dose showed about -19.5%. The 5 mg dose showed about -15.0%. These are averages, and results vary.

Like Saxenda®, Zepbound® is meant to be used with a lower-calorie diet and more activity. The shot supports those habits.

One note on the numbers. SCALE and SURMOUNT-1 were separate studies with different designs and lengths. So a direct one-to-one match is not clean.

In its trial, Saxenda® showed about -7.4% and Zepbound® at 15 mg showed about -20.9%. Different trials, different lengths, so read them side by side with care.

Daily vs weekly: how the dosing differs

This is where the two brands feel most different. Both start low and climb slowly, but on very different clocks.

Here is how Saxenda® (brand of liraglutide) steps up as a daily shot:

1. Saxenda® week 1: 0.6 mg once daily. This starting dose helps your body adjust.

2. Saxenda® week 2: 1.2 mg once daily.

3. Saxenda® week 3: 1.8 mg once daily.

4. Saxenda® week 4: 2.4 mg once daily.

5. Saxenda® week 5 and on: 3.0 mg once daily, the maintenance dose.

Zepbound® (brand of tirzepatide) climbs on a weekly clock instead. You inject it once a week, not every day.

1. Zepbound® starts at 2.5 mg once weekly for 4 weeks. This dose gets your body used to the drug.

2. Then it moves up to 5 mg once weekly, the first real treatment dose.

3. After at least 4 weeks, your doctor may add 2.5 mg at a time.

4. Weight maintenance doses for Zepbound® are 5 mg, 10 mg, or 15 mg once weekly.

5. The adult maximum for Zepbound® is 15 mg once weekly.

Missed a Zepbound® dose? You can take it within 4 days, or 96 hours. After that, skip it and wait for your next weekly day.

Never speed up your own climb on either brand. Faster is not better here. The slow ramp is what protects your stomach.

Your provider decides each step up. They look at how you feel and how you respond before adding more.

What to expect, and when

Results build slowly with both brands. The dose climbs over weeks, so changes are not instant. Give it time.

Some people notice less hunger in the first few weeks. Weight change usually shows up more clearly over months.

Remember the trial numbers ran long. SCALE measured Saxenda® at 56 weeks. SURMOUNT-1 measured Zepbound® at 72 weeks.

Those figures are averages, not promises. Your own path can be faster, slower, or simply different from the study.

Habits still matter a lot. Food, sleep, and movement work alongside the medicine, not against it.

The safety picture both brands share

Both brands share the same big caution. It is the boxed warning about thyroid C-cell tumors seen in animal studies.

Human risk is not confirmed. Still, the label says do not use either brand if MTC or MEN 2 runs in your family.

Pancreatitis is a separate label warning, not the boxed one. Watch for severe belly pain that may spread to your back, and call your doctor if it happens.

Stomach side effects are the most common. With Saxenda®, the label lists nausea, diarrhea, constipation, and vomiting.

The label also notes injection-site reactions, headache, low blood sugar, upset stomach, and tiredness. Most effects are mild and often ease with time.

Your family history is not a formality. With these drugs, it can rule the medicine out.

Which one is right for you?

You do not pick between Saxenda® and Zepbound® like paint colors. Your history, your goals, and your doctor drive the choice.

The daily versus weekly rhythm is a real factor. Some people like a daily habit. Others prefer one shot a week.

The size of the trial results also differs, as you saw above. Your clinician can help you read those numbers for your case.

Your health history matters too. Past pancreatitis, gallbladder trouble, or a family thyroid cancer history all shape the plan.

Insurance and coverage can differ by brand as well. That is a fair thing to raise with your provider early.

There is no wrong answer here, only a right fit. The best brand is the one you and your doctor can stick with safely.

Saxenda® and Zepbound® side by side

Here is the quick comparison, brand by brand, straight from the FDA labels and the named trials.

Brand	Medicine	FDA-approved use	Dosing schedule	Headline trial result
Saxenda®	Liraglutide	Chronic weight management	Daily shot, 0.6 mg up to 3.0 mg	SCALE: about -7.4% body weight vs -3.0% placebo, 56 wks, N=3,731
Zepbound®	Tirzepatide	Chronic weight management, plus moderate-to-severe OSA	Weekly shot, 2.5 mg up to 15 mg	SURMOUNT-1: about -20.9% at 15 mg vs -3.1% placebo, 72 wks, n=2,539

Saxenda® vs Zepbound® at a glance. Saxenda® weight data is from SCALE; Zepbound® weight data is from SURMOUNT-1.

Getting either brand: what actually matters

Once your doctor picks the brand, access is the next hurdle. This is where online GLP-1 providers come in. I judge them on how they operate, not on the medicine.

The FDA-approved product is the same wherever it is filled. So the fair questions are operational, not clinical.

Do they use a licensed 503A or 503B pharmacy?

Is there a real prescriber who reviews your history?

Do they help with dose titration and follow-up visits?

What is their refund policy if things do not work out?

Do they support insurance or coverage paperwork?

On those operational points, Refills Health is my top GLP-1 pick right now. Its pharmacy model, prescriber access, and follow-up support stand out.

I never claim one provider's medicine works better, because the branded medicine is the same. What differs is the service around it.

Titration help, quick messaging, and clear refund terms make a real difference. I break down the full field on our providers page.

Bring your prescription and your questions. A good provider earns your trust on service and safety, not on hype.

2. Pi-Sunyer X, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management (SCALE). NEJM 2015;373:11-22. NCT01272219. PMID 26132939.

5. Jastreboff AM, et al. Tirzepatide once weekly for obesity (SURMOUNT-1). NEJM 2022;387:205-216. NCT04184622.

Frequently asked questions

Are Saxenda® and Zepbound® the same drug?

No. They are two different medicines with one shared job. Saxenda® is a brand of liraglutide, and Zepbound® is a brand of tirzepatide. Both are FDA approved for chronic weight management in the right adults. The most obvious difference is timing. Saxenda® is a daily injection, while Zepbound® is a once-weekly injection.

How much weight did Saxenda® show in trials?

In the SCALE trial, Saxenda® showed about -7.4% mean body-weight change at 56 weeks. Placebo showed about -3.0%. The study enrolled 3,731 adults, split roughly 2,487 on Saxenda® and 1,244 on placebo. These figures are averages from the FDA label, so your own result can be higher, lower, or simply different.

How much weight did Zepbound® show in trials?

In the SURMOUNT-1 trial, Zepbound® at the 15 mg dose showed about -20.9% mean body-weight change at 72 weeks. Placebo showed about -3.1%. The 10 mg dose showed about -19.5%, and the 5 mg dose showed about -15.0%. The trial ran 72 weeks and enrolled 2,539 adults. Results are averages and vary by person.

Is Saxenda® or Zepbound® more effective for weight?

The two brands were studied in separate trials of different lengths, so a head-to-head number does not exist here. In its own trial, Saxenda® showed about -7.4% and Zepbound® at 15 mg showed about -20.9%. Read those side by side with care. Your clinician can help you weigh the results against your health and your goals.

How is the dosing different between the two?

Saxenda® is a daily shot. It climbs weekly from 0.6 mg to a 3.0 mg maintenance dose. Zepbound® is a once-weekly shot. It starts at 2.5 mg for four weeks, then moves to 5 mg, and can rise by 2.5 mg steps to a 15 mg maximum. Your doctor guides every step up.

Do both brands share the same warnings?

Yes, they share the same boxed warning about thyroid C-cell tumors seen in animal studies. Human risk is not confirmed. Do not use either brand if MTC or MEN 2 runs in your family. Pancreatitis is a separate warning to watch for. Stomach effects like nausea are the most common, and the slow dose climb is meant to ease them.

Can I switch from Saxenda® to Zepbound®?

A switch is a medical choice, not a swap you make alone. These are different medicines with different dosing, so your doctor sets a fresh plan and starting dose. Reasons to switch might include how a daily versus weekly shot fits your life, how you tolerate side effects, or your coverage. Ask your clinician which label fits your goals.

Important: This page is for education only and is not medical advice. Any medicines named here are available by prescription. Always talk to a licensed clinician about medicines, symptoms, or anything you are considering.